ELV DEADLINE TODAY: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Elevance Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 11 Deadline in Securities Class Action – ELV

Core Viewpoint - Rosen Law Firm is reminding purchasers of Elevance Health, Inc. common stock about the lead plaintiff deadline for a class action lawsuit related to misleading statements made by the company during the Class Period from April 18, 2024, to October 16, 2024 [1][4]. Group 1: Class Action Details - Investors who purchased Elevance common stock during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by July 11, 2025 [2]. - The lawsuit alleges that Elevance made false or misleading statements regarding the Medicaid redetermination process and its impact on the company's financial guidance [4]. Group 2: Allegations Against Elevance - The lawsuit claims that Elevance misrepresented its monitoring of cost trends associated with the Medicaid redetermination process, assuring investors that premium rates were sufficient to address risks [4]. - It is alleged that the acuity and utilization of Elevance's Medicaid members rose significantly, contrary to the company's assurances, leading to damages for investors when the truth was revealed [4]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time and being ranked No. 1 for the number of settlements in 2017 [3]. - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [3].